Matthew P Fox1, Sydney Rosen. 1. *Center for Global Health & Development, Boston University, Boston, MA; †Center for Global Health & Development Boston University School of Public Health, Boston, MA; and ‡Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Abstract
BACKGROUND: We previously published systematic reviews of retention in care after antiretroviral therapy initiation among general adult populations in sub-Saharan Africa. We estimated 36-month retention at 73% for publications from 2007 to 2010. This report extends the review to cover 2008-2013 and expands it to all low- and middle-income countries. METHODS: We searched PubMed, Embase, Cochrane Register, and ISI Web of Science from January 1, 2008, to December 31, 2013, and abstracts from AIDS and IAS from 2008-2013. We estimated retention across cohorts using simple averages and interpolated missing times through the last time reported. We estimated all-cause attrition (death, loss to follow-up) for patients receiving first-line antiretroviral therapy in routine settings in low- and middle-income countries. RESULTS: We found 123 articles and abstracts reporting retention for 154 patient cohorts and 1,554,773 patients in 42 countries. Overall, 43% of all patients not retained were known to have died. Unweighted averages of reported retention were 78%, 71%, and 69% at 12, 24, and 36 months, after treatment initiation, respectively. We estimated 36-month retention at 65% in Africa, 80% in Asia, and 64% in Latin America and the Caribbean. From lifetable analysis, we estimated retention at 12, 24, 36, 48, and 60 months at 83%, 74%, 68%, 64%, and 60%, respectively. CONCLUSIONS: Retention at 36 months on treatment averages 65%-70%. There are several important gaps in the evidence base, which could be filled by further research, especially in terms of geographic coverage and duration of follow-up.
BACKGROUND: We previously published systematic reviews of retention in care after antiretroviral therapy initiation among general adult populations in sub-Saharan Africa. We estimated 36-month retention at 73% for publications from 2007 to 2010. This report extends the review to cover 2008-2013 and expands it to all low- and middle-income countries. METHODS: We searched PubMed, Embase, Cochrane Register, and ISI Web of Science from January 1, 2008, to December 31, 2013, and abstracts from AIDS and IAS from 2008-2013. We estimated retention across cohorts using simple averages and interpolated missing times through the last time reported. We estimated all-cause attrition (death, loss to follow-up) for patients receiving first-line antiretroviral therapy in routine settings in low- and middle-income countries. RESULTS: We found 123 articles and abstracts reporting retention for 154 patient cohorts and 1,554,773 patients in 42 countries. Overall, 43% of all patients not retained were known to have died. Unweighted averages of reported retention were 78%, 71%, and 69% at 12, 24, and 36 months, after treatment initiation, respectively. We estimated 36-month retention at 65% in Africa, 80% in Asia, and 64% in Latin America and the Caribbean. From lifetable analysis, we estimated retention at 12, 24, 36, 48, and 60 months at 83%, 74%, 68%, 64%, and 60%, respectively. CONCLUSIONS: Retention at 36 months on treatment averages 65%-70%. There are several important gaps in the evidence base, which could be filled by further research, especially in terms of geographic coverage and duration of follow-up.
Authors: R E Barth; J T M van der Meer; A I M Hoepelman; P A Schrooders; D A van de Vijver; S P M Geelen; H A Tempelman Journal: Eur J Clin Microbiol Infect Dis Date: 2008-07-16 Impact factor: 3.267
Authors: Jean B Nachega; Michael Hislop; David W Dowdy; Joel E Gallant; Richard E Chaisson; Leon Regensberg; Gary Maartens Journal: AIDS Date: 2008-10-18 Impact factor: 4.177
Authors: Anna Funk; Steve Kanters; Margaret Nansubuga; Daniel Mwehire; Amber Featherstone; Eric Druyts; Mary Odiit; Edward J Mills Journal: Int J Epidemiol Date: 2012-11-19 Impact factor: 7.196
Authors: Ingrid Peterson; Oluwatoyin Togun; Thushan de Silva; Francis Oko; Sarah Rowland-Jones; Assan Jaye; Kevin Peterson Journal: AIDS Date: 2011-11-13 Impact factor: 4.177
Authors: Agnes N Kiragga; Barbara Castelnuovo; Rachel Musomba; Jonathan Levin; Andrew Kambugu; Yukari C Manabe; Constantin T Yiannoutsos; Noah Kiwanuka Journal: PLoS One Date: 2013-12-31 Impact factor: 3.240
Authors: Duc Bui Nguyen; Nhan Thi Do; Ray W Shiraishi; Yen Ngoc Le; Quang Hong Tran; Hai Huu Nguyen; Nicholas Medland; Long Thanh Nguyen; Bruce Baird Struminger Journal: PLoS One Date: 2013-02-15 Impact factor: 3.240
Authors: Norma C Ware; Monique A Wyatt; Elvin H Geng; Sylvia F Kaaya; Oche O Agbaji; Winnie R Muyindike; Guerino Chalamilla; Patricia A Agaba Journal: PLoS Med Date: 2013-01-08 Impact factor: 11.069
Authors: Asgeir Johannessen; Ezra Naman; Bernard J Ngowi; Leiv Sandvik; Mecky I Matee; Henry E Aglen; Svein G Gundersen; Johan N Bruun Journal: BMC Infect Dis Date: 2008-04-22 Impact factor: 3.090
Authors: Katherine B Rucinski; Sheree R Schwartz; Kimberly A Powers; Brian W Pence; Benjamin H Chi; Vivian Black; Helen Rees; Audrey E Pettifor Journal: AIDS Behav Date: 2020-06
Authors: Alison L Drake; Jennifer A Unger; Keshet Ronen; Daniel Matemo; Trevor Perrier; Brian DeRenzi; Barbra A Richardson; John Kinuthia; Grace John-Stewart Journal: Contemp Clin Trials Date: 2017-03-14 Impact factor: 2.226
Authors: Kate Clouse; Molebogeng Motlhatlhedi; Kemberlee Bonnet; David Schlundt; David M Aronoff; Rosette Chakkalakal; Shane A Norris Journal: AIDS Care Date: 2018-05-30
Authors: Mark W Tenforde; Margaret Mokomane; Tshepo Leeme; Raju K K Patel; Nametso Lekwape; Chandapiwa Ramodimoosi; Bonno Dube; Elizabeth A Williams; Kelebeletse O Mokobela; Ephraim Tawanana; Tlhagiso Pilatwe; William J Hurt; Hannah Mitchell; Doreen L Banda; Hunter Stone; Mooketsi Molefi; Kabelo Mokgacha; Heston Phillips; Paul C Mullan; Andrew P Steenhoff; Yohana Mashalla; Madisa Mine; Joseph N Jarvis Journal: Clin Infect Dis Date: 2017-09-01 Impact factor: 9.079
Authors: Chris T Longenecker; Stephen R Morris; Twalib O Aliku; Andrea Beaton; Marco A Costa; Moses R Kamya; Cissy Kityo; Peter Lwabi; Grace Mirembe; Dorah Nampijja; Joselyn Rwebembera; Craig Sable; Robert A Salata; Amy Scheel; Daniel I Simon; Isaac Ssinabulya; Emmy Okello Journal: Circ Cardiovasc Qual Outcomes Date: 2017-11
Authors: Lillian B Brown; Diane V Havlir; James Ayieko; Florence Mwangwa; Asiphas Owaraganise; Dalsone Kwarisiima; Vivek Jain; Theodore Ruel; Tamara Clark; Gabriel Chamie; Elizabeth A Bukusi; Craig R Cohen; Moses R Kamya; Maya L Petersen; Edwin D Charlebois Journal: AIDS Date: 2016-11-28 Impact factor: 4.177
Authors: Nanina Anderegg; Jonas Hector; Laura F Jefferys; Juan Burgos-Soto; Michael A Hobbins; Jochen Ehmer; Lukas Meier; Marloes H Maathuis; Matthias Egger Journal: J Clin Epidemiol Date: 2020-08-20 Impact factor: 6.437
Authors: Daniel S Teixeira da Silva; Paula M Luz; Jordan E Lake; Sandra W Cardoso; Sayonara Ribeiro; Ronaldo I Moreira; Jesse L Clark; Valdilea G Veloso; Beatriz Grinsztejn; Raquel B De Boni Journal: AIDS Care Date: 2016-07-27